Scott Ullem: Thanks Gene, good morning everyone. As Gene mentioned, I will wrap up the commentary this morning with details of our cash flows during the quarter, and on our earnings guidance for the rest of the year. Cash flow from operations decreased in the first quarter of 2010 due primarily to $118 million swing in working capital. Historically, due to the seasonality in our flexible packaging business, we use cash for working capital during the first quarter and that is what happened this year. This is due to the normal buildup of inventory in March to support strong second quarter shipments. In addition, higher March sales increased accounts receivable balances in the first quarter. A year ago during the first quarter of 2009, cash flow from operations included substantial working capital improvements as order volumes were softer and raw material costs were declining. This improvement delivered $53 million of positive cash flow to the first quarter of last year. During the first quarter of 2010, we faced increasing raw material cost, and strengthening sales order volumes for which we were building accounts receivable and inventory levels. As a result, working capital balances increased and resulted in a use of cash totaling $66 million by the end of March. Looking forward to the rest of the year, working capital management continues to be a major focus. We expect working capital to once again be a source of cash flow for the total year. This quarter we also made a $15 million voluntary tax-deductible pension contribution in order to improve the funded status of our pension plans. We do not intend to make any additional contribution in 2010. Net income in the first quarter of 2010 included cash expenses totaling about $15 million for acquisition related professional fees and taxes. This compares to cash paid for such fees in the first quarter of 2009 of about $3 million, the difference resulting in another $12 million use of cash in 2010. The Food Americas business is integrating with Bemis and delivering the value that will quickly generate strong cash flow. The proceeds from the expected sale of the discontinued operations and additional near term cash flow will be used for debt reduction. We will continue to prioritize our use of cash for debt reduction, growth focused capital spending, sustainable dividends, complementary acquisitions, and opportunistic share repurchases. While we are not providing specific cash from operations guidance, we do expect cash from operations in 2010 to be a healthy step up from the past few years with additional cash generating power of the Food Americas business. Capital expenditures totaled only $18 million this quarter, but we expect this to catch up to more normal levels through the rest of the year. We now expect 2010 capital expenditures to be in the $160 million to $170 million range including the needs of the acquired facilities. This means that once again our capital expenditures will be well below depreciation and amortization in 2010. We expect annualized depreciation and amortization going forward including acquisition related purchase accounting adjustments to be in the range of $210 million to $220 million. It is important to note that over the long term, we believe capital spending for our business should be approximately equal to depreciation and amortization. Turning now to earnings per share guidance, we are increasing our guidance for full year 2010 adjusted earnings per share from continuing operations by $0.05 to a range of $2.00 to $2.15. Consisting with the approach we have used in the past, our guidance excludes the $0.06 pre-acquisition impact of acquisition financing in the months of January and February when we did not yet own the Food Americas business. Guidance for the second quarter for earnings from operations excluding the impact of transaction related costs and inventory related purchase accounting is $0.53 to $0.58 per share. Several positive factors are driving the increase in our 2010 EPS guidance as compared to the guidance we provided last month. We are ahead of schedule in capturing cost savings synergies from the Food Americas acquisition. In addition, we have slightly higher expectations for growth in our key flexible packaging markets and our world-class manufacturing initiatives are showing attractive momentum for the rest of the year. Offsetting some of the positive momentum is the raw material price increases we are experiencing. In aggregate, we expect these factors to help drive earnings per share from continuing operations $0.05 higher than we projected last month to a range of $2.00 to $2.15. Now, we would like to open the call for any questions.
Scott Ullem: Let me answer both questions the same time. First is to confirm, yes, over the long term we expect capital expenditures to be roughly in line with depreciation and amortization. The facilities that we acquired had clearly received a lot of healthy capital expenditures and capital investments over the last six years from the previous owners. And so we have been very pleased with the modern condition of those facilities and the capacity that they bring to us, and in general we are very pleased with what we bought and that is influencing our capital expenditure plans for this year.
Scott Ullem: I guess simply put, our cash flow from operations last year was – we were pleased with the cash flow and it reflects a lot of the working capital improvements that we have made by focusing on reducing cash cycle days, and really improving our working capital utilization. Alcan has done some of that as well and we believe we are going to be able to bring to bear some of our experience in improving working capital and really focusing on cash flow to the Alcan operations in total we think it is going to be incremental to what Bemis has been able to do historically on our own.Sara Magers – Wells Fargo Securities: Okay and just a follow-up on that, just wondering a little bit about that inventory write-up, what exactly was it? I mean I know that resin has been kind of certainly high here, I am just wondering if there is a potential for any kind of reversal if resin were to fall off the cliff, which would be nice.
Scott Ullem: We have not put anything together publicly on that so we are going to have other kind of transactions to deal with, you have transaction costs to deal with, with the sale of our discontinued operation. There will be some effect of inventory that had to be written up. We have roughly 60 to 75 day turn in that inventory but we should be though most of it by the end of the second quarter.
Henry Theisen: The contracts that they have for escalators, de-escalators are very similar to ours. They sometimes have a little more six month and we are a little more three month but the basic premise of them are the same.Ghansham Panjabi – Robert W Baird: Okay, thank you.
Henry Theisen: Tim, this is Henry. The thing that I find interesting talking about CapEx is the more higher valued areas, the areas where complementary technologies are being brought to Bemis, I see some good uses of CapEx there to grow our business, and I see some good new products coming out of the technology. So, we will have some CapEx investments at those growth platforms.
Henry Theisen: You know it is in our DNA to create new products and look at these synergies and the talent levels and the different technologies I can see blending to make a lot of new products. But I also see a lot of other synergies where we have technologies that will help them, they have technologies that will help our product lines, and we also have product lines that I think will help each other, maybe they make a thermal foam tray and we can make the lid stock and add to the sealing capabilities. So I think there are a lot of areas where we are going to be complementary to each other and the synergies where we make retail cheese, they make wax coated products. We are going to have a lot of good synergies. Especially a lot of the customers we have here, we sell to one segment of the customer’s business and they will sell to another segment of the customer’s business. So it will make us more valuable to our customers.
Henry Theisen: No actually Sara, this is related to purchase accounting entirely and as you know, in purchase accounting, we have to write those up to basically help the market value and that will go through the P&L relatively quickly, go through over the inventory turn, so it will be gone by the end of next quarter.
Henry Theisen: You know the March that we had I think is consistently with the past Marchs. We always have a nice uptick in business in March as we switch through the seasons. I do not see it being that drastically different than patterns in the past. You know some of the areas where I see growth in the flexible packaging business are relating to the rigid tray business. We are substantially growing our PET business with rigid trays, we are like sliced luncheon meats that we have shown around. Alcan has technologies in the rigid trays for retort packaging, for crystallizable PET. I see those rigid technologies as really having a good merit and driving a lot of good sales with it. I also see the technologies in multilayer films that will go into our perfect seal our medical device, the acquisition of the pharmaceutical business is going to give us some extra technologies to expand, the quality of convenience food marketing, the desire for extended shelf life, all of those things that go into a high barrier product lines are going to drive future growth of flexible packaging.
Henry Theisen: I think because of the extended time period that the DOJ did, we had a lot of time to plan exactly what resources we are going to need and how we are going to go forward with them. So we were prepared in our initial 100-day plan to react very quickly to the people needs, and to which people we need, and where they are going to be situated, and that is basically what is concluded in March.
Henry Theisen: I think that is the target that we started with when we started looking at the acquisition. We are used to competing with Alcan day in and day out, and there is no reason that we cannot get the margins over time at Alcan to be at the same levels as Bemis has.
Henry Theisen: You know, most of the people that we have or most of our key customers have contracts, and those contracts can go from three to five years, some will go all the year, some will go into two, some will go in three. So it will have to work through the time period of those contracts.
Henry Theisen: We still stand by the things we talked about in the past. We would like to drill the Bemis Company half with acquisitions and half to organic growth. If there is an acquisition that comes along this year that makes good sense for Bemis that increases our technology gives good geographic reach or some customer relationship, we are prepared to act on that.
Henry Theisen: We see ourselves growing internationally, more so we have excellent operations in Brazil and with the gain in Mexico, I feel there is a good growth pattern in Latin America. We do not have much in Asia but we did pick up a small plant, which I think in the protein area will give some opportunities to grow. Our pharma and medical business has good growth opportunities on a global basis, and finally I am not going to give up our North America’s food business. I think the areas that have the technology will continue to grow for the Bemis Company.
Henry Theisen: Good morning, Benjamin.Benjamin Wong – Bank of America: Good morning. We have seen some signs of pick up in the retail point of sales data for packaged food products. I was curious to know maybe what your customers are saying about the state of consumer. And then as a follow-up, are there any new film technologies that Bemis is particularly upbeat about? Thanks.
Henry Theisen: I think the technologies that we acquired from Alcan are along the retail area and retort is very important for us and we see that being very additive to our company. As far as what our customers are seeing, I really do not feel in a position to comment on that.Benjamin Wong – Bank of America: Okay, thanks.
Henry Theisen: No, I do not. I think Alcan and Bemis are very good complementary companies, and you are not going to see much of a change in those patterns.
Henry Theisen: Our escalated, de-escalated contracts will pass those raw material increases through. Divisionally, we have presidents and we have people and that is how we are organized and they know that in order for them, their targets, their pay, they have to pass those along because they cannot allow them to hit the bottom line. So we have a strong culture of being able to pass through those price increases and that has not changed and will not change. As far as what we see the raw materials, this is a guess, everybody has a guess on what is going to go on with raw materials but we have seen quite a run up in the first quarter here. We expect it to be flat for a while and maybe slightly drop later in the year.
Henry Theisen: You know, we really do not have a very good way of quantifying new innovative products. A lot of those products are just the normal flow where you increase the performance or you use alternative [ph] materials to control the pricing of those products or their slight modification. So a lot of it is generally just kind of go with time and you will see the product progress. They are not like major launches of platforms that you have. As far as competitive pressures, this is still a very fragmented business. There is a lot of competition out there. The competition is both here in North America. Competition comes from abroad, even with the combination of Bemis and Alcan, there is still a lot of companies out there, a lot of competitive pressures, and the more technologies in the product and the more you can add convenience to features, to shelf life, to food safety, the more you can protect your program. On the other hand, the more that it is like a bread bag that you cannot really change in those areas you have more competitive pressure. I do not see this being any different than at any other time.
Henry Theisen: Well Sara, as we look going forward in this remainder of the year, we certainly have a lot of challenges as we go through a lot of integration. There is going to be a lot of cost we have to deal with as we start to optimize our plans, we will start to figure out some of these causes, we may have to re-qualify certain kinds of customers. So we are going to have some costs there plus we have the headwind we are dealing with right now with raw materials although we expect that to flatten out as the year progresses, it takes time for us to catch up on those price increases and last year at this time, we were benefitting from falling raw material cost that benefitted our margins. This year we are going into the second-half of the year with rising prices that we have to pass it on to the customers over the next few months. So I think we have more headwinds this year than we had last year as we went forward.Sara Magers – Wells Fargo Securities: Okay, thank you.
Henry Theisen: You know our volumes in our roll label business here in North America picked up very nicely in the first quarter and I think that is going to continue. I do not think that was just a filler in the product line. The economy is a little better than it was a year ago and I think that will continue to grow through the rest of the year. We also have some good new products coming out in our pressure sensitive area and into some of the technical areas and leveraging with our medical business. So that is a good sign in North America. Europe continues to be slow. The economy there I think is slow. A lot of that business is really in the graphics area and it really has not jumped up for advertising of some of those points of display. I look for a little more growth out of North America and Europe to struggle a little bit. But although Europe was slow, the volume increased year over year. So that is a good sign in Europe for us that it is starting to increase but North America was much stronger.
